Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Addition of a PEP or O-PEP Device to Nebulization With Hypertonic Saline in Patients With Cystic Fibrosis During Exacerbation

NCT06964074 is registered in ClinicalTrials.gov with National Institute for Tuberculosis and Lung Diseases, Poland as lead sponsor.

NCT NCT06964074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06964074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Addition of a PEP or O-PEP Device to Nebulization With Hypertonic Saline in Patients With Cystic Fibrosis During Exacerbation
Lead sponsor
National Institute for Tuberculosis and Lung Diseases, Poland
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 1, 2022
Completion date
December 1, 2025
Enrollment
70 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis